Purchase Order 75F40124P00319
Award Date
7/23/24
Potential Completion Date
12/31/24
Potential Value
$25K
Federal Agency
Food and Drug Administration
Awardee
Qiagen Sciences LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
B504 - Special Studies/Analysis- Chemical/Biological
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
NEW CARROLLTN, MD 20784, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Qiagen, LLC, a division of the biotechnology company Qiagen N.V. The contract, awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), has a ceiling value of $107,401.82 and is a firm fixed-price purchase order with an ultimate completion date of August 22, 2019. The contract provides for the addition of funding to an original requisition, without any set-aside designation. Qiagen, a...
This is a $147,859.57 firm fixed-price delivery order issued under the Qiagen IDIQ contract (75F40121D00009) by the Food and Drug Administration (FDA), a civilian federal agency. The order is for the purchase of molecular biology reagents, with no set-aside designation. The prime contractor is Qiagen, LLC, a foreign-owned, for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. Qiagen, LLC is...
The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $21,705.02 contract is for gene expression analysis services. The award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. These offerings include DNA/RNA extraction...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
This is a delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $27,299.50 firm fixed price contract does not have a set-aside designation. Qiagen has provided a range of goods and services to support federal biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing,...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Delivery Order contract to Qiagen, LLC, a division of Qiagen N.V., for the purchase of molecular biology reagents. The $149,040.91 contract has a completion date of September 26, 2022. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has previously provided products and services like DNA/RNA extraction kits,...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic analysis products. The $389,994.64 contract, which does not have a set-aside designation, is for the delivery of various scientific equipment and consumables to support NIEHS's biomedical research and public health initiatives. Key items included under the contract are DNA/RNA...